Ikarian Capital, LLC 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:20 pm Purchase | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | Ikarian Capital, LLC | 617,667 4.990% | 8,442 (+1.39%) | Filing |
| 2025-02-14 1:15 pm Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | Ikarian Capital, LLC | 609,225 9.500% | 609,225 (New Position) | Filing |